Mutations in PAK1 cause a neurodevelopmental disorder
The American Journal of Human Genetics recently published de novo mutations in PAK1, encoding p21-activated kinase 1, in two unrelated subjects. These mutations were associated with developmental delay, secondary macrocephaly, seizures, and ataxic gait, probably via gain-of-function. The authors postulate that this phenotype, along with developmental disorders associated with RAC1 and CDC42 mutations, highlight the importance of RHO GTPase membres and effectors in neuronal development.